Standards; Pharmaceutical/API Drug Impurities/Metabolites;
An irreversible a-antagonist. Used in the treatment of hypertension, it has a relatively slow onset and prolonged effect when compared to alternative a-blockers.
Portoghese, P., et al.: J. Med. Chem., 14, 561 (1971), Berry, D., et al.: Eur., J. Pharmacol., 28, 164 (1974),
400-821-0725
沪ICP备17019645号
